Eli Lilly & Co.: The Indianapolis drug...
- Share via
Eli Lilly & Co.: The Indianapolis drug firm reported that third-quarter earnings climbed 24% from a year ago to a record $212.4 million. Sales totaled a record $1.05 billion, a gain of 11%. The results were attributed to higher volume in both pharmaceuticals and medical instruments.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
